Volume 3, Issue 3, September 2019, Page: 55-61
Immediate Outcome and Predictors of Percutaneous Mitral Balloon Commissurotomy: A 5 Years Experience in Cardiac Center Ethiopia
Mohammed Bedru Sebah, Cardiac Center of Ethiopia, Addis Ababa, Ethiopia
Kefelegn Dejene Tadesse, Cardiac Center of Ethiopia, Addis Ababa, Ethiopia
Ali Dawed Mohammed, Cardiac Center of Ethiopia, Addis Ababa, Ethiopia
Fekede Agwar Debel, Cardiac Center of Ethiopia, Addis Ababa, Ethiopia
Shibikom Tamirat Agonafir, Cardiac Center of Ethiopia, Addis Ababa, Ethiopia
Azene Dessie Mengistu, Cardiac Center of Ethiopia, Addis Ababa, Ethiopia
Jemal Haidar Ali, Department of Public Health Nutrition, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia
Received: Jul. 23, 2019;       Accepted: Aug. 18, 2019;       Published: Sep. 4, 2019
DOI: 10.11648/j.ccr.20190303.13      View  94      Downloads  22
Abstract
Percutaneous mitral balloon commissurotomy (PMBC) is the treatment of choice for rheumatic mitral stenosis with favorable anatomy and prevents complications inherent to a surgical procedure, while maintaining effectiveness. In view of this, we examined the immediate outcome and its predictors of patients undergoing PMBC in our Cardiac Center and availed evidence based information for future use of the treatment in Ethiopia. A retrospective data analysis of 330 patients with symptomatic severe mitral stenosis treated with PMBC using Inoue balloon in the cardiac center Ethiopia from 2014 to 2018 were assessed for their clinical outcome for those who presented for the first time in our cardiac center, Addis Ababa. Demographic, clinical, echocardiographic and hemodynamic data of all patients with symptomatic severe mitral stenosis were collected and analyzed. Of the 330 PMBC performed during the 5 years in the center, the majority had successful procedure (97.88%) and optimal result (92.42%). Twenty four (7.2%) had complications of which 7 (2.1%) had failed procedure and 9 (2.7%) marked mitral regurgitation. Atrial fibrillation was observed in 67 (20.3%). The mean mitral valve score (MVS) was 7.3± 1.35 ranged from 4 to 13. A significant association of immediate outcome was observed with atrial fibrillation (AOR=4.41; 95% CI=1.51 to 12.89) and high mitral valve total Wilkins score (AOR=0.25; 95% CI 0.09 to 0.70). The major predictors identified for poor outcome are atrial fibrillation and MVS. Percutaneous mitral balloon commissurotomy is a safe procedure with excellent immediate results signifying that it is a treatment of choice for heterogeneous group of patients with rheumatic mitral stenosis.
Keywords
Percutaneous Mitral Balloon Commissurotomy, Predictors, Cardiac Center Ethiopia
To cite this article
Mohammed Bedru Sebah, Kefelegn Dejene Tadesse, Ali Dawed Mohammed, Fekede Agwar Debel, Shibikom Tamirat Agonafir, Azene Dessie Mengistu, Jemal Haidar Ali, Immediate Outcome and Predictors of Percutaneous Mitral Balloon Commissurotomy: A 5 Years Experience in Cardiac Center Ethiopia, Cardiology and Cardiovascular Research. Vol. 3, No. 3, 2019, pp. 55-61. doi: 10.11648/j.ccr.20190303.13
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Lung B, Baron G, ButchartEG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43.
[2]
Carapetis JR, SteerAC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases: a population based study. Lancet Infect Dis 2005; 5: 685-94.
[3]
Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357: 470-6.
[4]
Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med 1960; 52: 741-9.
[5]
Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ 1981; 59: 285.
[6]
Borger MA, CarrelTP, DeBonis M, et al. The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-96.
[7]
Bonow RO, Carabello BA, Chatterjee K, et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 Focused update incorporated into the ACC/ACC 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2008; 52: e1-142.
[8]
Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-68.
[9]
Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984; 87: 394-402.
[10]
Nobuyoshi M, Arita T, Shirai SI, et al. Percutaneous balloon mitral valvuloplasty a review. Circulation. 2009; 119 (8): e211ee219.
[11]
Nair KK, Pillai HS, Thajudeen A, et al. Comparative study on safety, efficacy, and midterm results of balloon mitral valvotomy performed with triple lumen and double lumen mitral valvotomy catheters. Cathet Cardiovasc Interv. 2012; 80 (6): 978e986.
[12]
Ben-Farhat M, Betbout F, Gamra H, et al. Predictors of long-term event-free survival and of freedom from restenosis after percutaneous balloon mitral commissurotomy. Am Heart J. 2001; 142 (6): 1072e1079.
[13]
Vahanian A. Percutaneous mitral commissurotomy: an effective treatment in ‘ideal’ candidates whatever the approach. Eur Heart J 1997; 18 (11): 1689-90.
[14]
Vahanian A, Iung B. Percutaneous mitral balloon commissurotomy: a useful and necessary treatment for the western population. Eur Heart J 2000; 21 (20): 1651-2.
[15]
Thomas T, Ananthakrishna R, Chikkabasavaiah NA, Basavappa R. Application of a novel percutaneous transluminal mitral commissurotomy technique in deformed mitral valve. BMJ Case Rep 2011; 2011.
[16]
Ootaki Y, Kozawa S, Asada T, Mukohara N, Higami T, Iwahashi K. Rupture of the papillary muscle after percutaneous transvenous mitral commissurotomy (PTMC) —a case report. Nihon Kyobu Geka Gakkai Zasshi 1997; 45 (10): 1738-42.
[17]
Earley MJ. How to perform a transseptal puncture. Heart. 2009; 95 (1): 85e92.
[18]
Nishimura RA, Holmes DRJr, Reeder GS. Percutaneous balloon valvotomy. Mayo Clin Proc 1990; 65: 198-220.
[19]
Complications and mortality of percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvotomy Registry. Circulation 1992; 85: 2014-24.
[20]
Bouleti C, Iung B, Himbert D, et al. Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. Eur Heart J 2013; 34: 1923.
[21]
Kim D, Chung H, Nam JH, et al. Predictors of Long-Term Outcomes of Percutaneous Mitral Valvuloplasty in Patients with Rheumatic Mitral Stenosis. Yonsei Med J 2018; 59: 273.
[22]
Song H, Kang DH, Kim JH, et al. Percutaneous mitral valvuloplasty versus surgical treatment in mitral stenosis with severe tricuspid regurgitation. Circulation 2007; 116: I246.
[23]
Block PC, Palacios IF, Jacobs MC, Fallon JT. Mechanisms of percutaneous mitral valvotomy. Am J Cardiol 1987; 59: 318-23.
[24]
Kim MJ, Song JK, Song JM, et al. Long-term outcomes of significant mitral regurgitation after percutaneous mitral valvuloplasty. Circulation 2006; 114: 2815.
[25]
Sutaria N, Northridge DB, Shaw TRD. Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart 2000; 84: 398-402.
[26]
Padial LR, Freitas N, Sagie A, et al. Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvotomy. J Am Coll Cardiol 1996; 27: 1225-31.
[27]
Wilkins GT, Weyman AE, AbascalVM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988; 60 (4): 299e308.
[28]
Friedrich SP, Berman AD, Baim DS, Diver DJ. Myocardial perforation in the cardiac catheterization laboratory: incidence, presentation, diagnosis, and management. Cathetcardiovasc Diagn 1994; 32: 99-107.
[29]
Teresa S M Tsang, William K Freeman, Marion E Barnes Ms, Guy S Reeder, Douglas L Packer, James B Sward. Rescue Echocardiographically Guided Pericardiocentesis for cardiac perforation complicating catheter-based procedures- the Mayo Clinical Experience JACC 1998: 32 (5): 1345-50.
[30]
Hung J-S. Mitral stenosis with left atrial thrombi: Inoue balloon catheter technique. In: Cheng TO, editor. Percutaneous Balloon Valvuloplasty. New York, NY: Igaku-Shoin, 1992: 280-93.
Browse journals by subject